LOGOLOGOLOGOLOGO
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Impact of the EU’s General Pharmaceutical Legislation on Europe’s innovation ecosystem and biotechnology companies
      • Patient BioForum
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biomanufacturing In Our Lives
  • Activities
    • 25 Years of Innovation
    • Boosting Biotechnology and Biomanufacturing in the EU
    • European Biotech Week
    • PRIMED Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Factsheet – Supporting small biotechs in the revision of EU pharmaceutical legislation

02/11/2023
FACTSHEET

SUPPORTING SMALL BIOTECHS IN THE REVISION OF EU PHARMACEUTICAL LEGISLATION

Small biotech companies are the unsung heroes of the healthcare industry, driving innovation and improving patient access. They've been pivotal in developing transformative therapies and technologies. Collaboration is key to their success, but they face challenges.

EU Pharmaceutical Legislation has been a game-changer, boosting small biotechs' share of the R&D pipeline from 30% to 60% in 20 years.

Now, it's time to strengthen Europe's innovation ecosystem even further for small biotechs.

Share
Adrian Lincoln
Adrian Lincoln

Related posts

01/07/2024

Biotech Starter Kit – The EU General Pharmaceutical Legislation

Read more
25/06/2024

EuropaBio response to the public consultation on the revision of the EU Variation Regulation

Read more
24/06/2024

Biotech Starter Kit – Compulsory Licensing for Crisis Management

Read more

Important links

  • Hidden Heroes: How microorganisms are shaping Europe’s future
  • Biotechnology in the framework of Europe’s agri-food future

Categories in our Newsroom

EBIO-white
EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.
Contact us
Extra links
Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom
Become a member
Media pack
© 2024 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

Algal Omega 3

Algal Omage-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of algal omega-3 used.